Use the Search Fields to Find Information
Page 90 of 373
Prenatal cannabis exposure predicts attention problems, without changes on fMRI in adolescents
Please use this link to access this publication. Abstract Objectives We hypothesized that prenatal cannabis exposure (PCE) would be associated with increased attention problems and
March 20, 2024
Prenatal cannabis exposure in the clinic and laboratory: What do we know and where do we need to go?
Abstract Coincident with the legalisation of cannabis in many nations, rates of cannabis use during pregnancy have increased. Like prior investigations on smoking and alcohol, understanding how
November 8, 2025
Prenatal cannabis exposure and the risk for neuropsychiatric anomalies in the offspring: a systematic review and meta-analysis
Please use this link to access this publication. Abstract Objective To evaluate the association between cannabis use during pregnancy and the risk for long-term neuropsychiatric
October 30, 2025
Prenatal Cannabinoid Exposure: Emerging Evidence of Physiological and Neuropsychiatric Abnormalities
Abstract Clinical reports of cannabis use prevalence during pregnancy vary widely from 3% to upwards of 35% in North America; this disparity likely owing to
March 29, 2024
Prenatal Cannabinoid Exposure Elicits Memory Deficits Associated with Reduced PSA-NCAM Expression, Altered Glutamatergic Signaling, and Adaptations in Hippocampal Synaptic Plasticity
Abstract Cannabis is now one of the most commonly used illicit substances among pregnant women. This is particularly concerning since developmental exposure to cannabinoids can
December 6, 2023
Prenatal cannabinoid exposure and the developing brain: Evidence of lasting consequences in preclinical rodent models
Please use this link to access this publication. Abstract Cannabis use by people who are pregnant is increasing. Understanding how prenatal cannabinoid exposure (PCE) affects infants and
March 22, 2026
Preliminary, open-label, pilot study of add-on oral Δ9-tetrahydrocannabinol in chronic post-traumatic stress disorder
Abstract Background and objectives: Many patients with post-traumatic stress disorder (PTSD) achieve but partial remission with current treatments. Patients with unremitted PTSD show high rates of
September 19, 2019
Preliminary Investigation of the Safety of Escalating Cannabinoid Doses in Healthy Dogs
Objective: To determine the safety and tolerability of escalating doses of three cannabis oil formulations, containing predominantly CBD, THC, or CBD and THC (1.5:1) vs. placebo
October 28, 2021
Preliminary in vivo evidence of lower hippocampal synaptic density in cannabis use disorder
Please use this link to access this publication. Abstract Cannabis is one of the most commonly and widely used psychoactive drugs. The rates of cannabis
June 21, 2025
Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis
Abstract Objectives: To assess the efficacy of a cannabis-based medicine (CBM) in the treatment of pain due to rheumatoid arthritis (RA). Methods: We compared a
September 7, 2021
Page 90 of 373